172 related articles for article (PubMed ID: 19875959)
1. Heterogeneity of response to asthma controller therapy: clinical implications.
Langmack EL; Martin RJ
Curr Opin Pulm Med; 2010 Jan; 16(1):13-8. PubMed ID: 19875959
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
[TBL] [Abstract][Full Text] [Related]
3. Genetics and the variability of treatment response in asthma.
Israel E
J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036
[TBL] [Abstract][Full Text] [Related]
4. Critical appraisal of antileukotriene use in asthma management.
Polosa R
Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in antileukotriene therapy.
Scadding GW; Scadding GK
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):370-6. PubMed ID: 20585242
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of asthma.
Hawkins GA; Peters SP
Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
[TBL] [Abstract][Full Text] [Related]
7. Asthma in smokers: challenges and opportunities.
Thomson NC; Chaudhuri R
Curr Opin Pulm Med; 2009 Jan; 15(1):39-45. PubMed ID: 19077704
[TBL] [Abstract][Full Text] [Related]
8. Complementary therapy in asthma: inhaled corticosteroids and what?
Bjermer L; Diamant Z
Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
11. TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma.
Kim JH; Lee SY; Kim HB; Jin HS; Yu JH; Kim BJ; Kim BS; Kang MJ; Jang SO; Hong SJ
Clin Exp Allergy; 2008 Jan; 38(1):51-9. PubMed ID: 18031559
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms.
Dijkstra A; Koppelman GH; Vonk JM; Bruinenberg M; Schouten JP; Postma DS
J Allergy Clin Immunol; 2008 Jun; 121(6):1510-3. PubMed ID: 18539200
[No Abstract] [Full Text] [Related]
13. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
14. [Leukotriene antagonists].
Mallet JP
Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
[TBL] [Abstract][Full Text] [Related]
15. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical treatment strategies for childhood asthma.
Carlsen KH; Carlsen KC
Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):168-76. PubMed ID: 18317028
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in response to asthma medications.
Tamesis GP; Krawiec ME
Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):185-9. PubMed ID: 17351474
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene antagonists. Do they offer new hope for asthmatics?
Thien F
Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
20. Antileukotriene agents in asthma: the dart that kills the elephant?
Renzi PM
CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
